MetaCap

Evogene (EVGN) vs Nexentis Technologies (NXTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Evogene is the larger company by market cap ($6.5 million vs $1.6 million), about 4.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

EVGN versus NXTS key metrics
MetricEVGNNXTS
Share price$0.4106$1.08
Market cap$6.49M$1.57M
1-day change-3.09%-22.30%
EPS (TTM)$-1.60$-16.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.50$32.90
52-week low$0.35$0.94
Distance from 52-week high-72.63%-96.72%
Average volume2.02M53.55K
Shares outstanding15.80M1.45M
SectorIndustrialsIndustrials
IndustryAgricultural ChemicalsAgricultural Chemicals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Evogene is about 4.1 times larger than Nexentis Technologies by market value ($6.49M vs $1.57M).

EVGN vs NXTS FAQ

Which is bigger, Evogene or Nexentis Technologies?

Evogene (EVGN) is larger, with a market capitalization of $6.49M compared with $1.57M for Nexentis Technologies (NXTS).

Are Evogene and Nexentis Technologies in the same industry?

Yes. Both are classified in the Agricultural Chemicals industry within the Industrials sector.

More comparisons